Skip to main content
. 2026 Jan 27;18(1):113475. doi: 10.4254/wjh.v18.i1.113475

Table 7.

Cut-off validation against established thresholds

Marker
Established cut-off
Our cut-off
Clinical utility
FIB-4 > 1.45 (rule-out) > 1.42 Equivalent rule-out
APRI > 0.7 (significant) > 0.68 Validated threshold
PLR Novel marker > 142.5 Exploratory
NPAR Novel marker > 14.13 Exploratory

FIB-4: Fibrosis index based on four factors; APRI: Aspartate transaminase to platelet ratio index; PLR: Platelet-to-lymphocyte ratio; NPAR: Neutrophil percentage-to-albumin ratio.